Nebula Research & Development »

Fate Therapeutics shares owned by Nebula Research & Development

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Nebula Research & Development from 13F filings

Historical chart of Nebula Research & Development investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Nebula Research & Development consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Nebula Research & Development

Quarter filed Position value Share count Share price at filing
2023-09-30 $347k 164k 2.12
2023-06-30 $203k 43k 4.76